Prosecution Insights
Last updated: October 26, 2026

Stephen Thomas Kapushoc, USPTO Patent Examiner

Listed by the USPTO as KAPUSHOC, STEPHEN THOMAS

Tech Center 1700 • Art Units: 1634 1682 1683 1699 1758

This examiner grants 46% of resolved cases

Analysis

KAPUSHOC, STEPHEN THOMAS is assigned to tech center 1700 and art unit 1634. The profile covers 742 resolved cases, with an allowance rate of 46.5% and a median of 1378 days to allowance. Interviews correspond to a 53.8% lift in the recorded allowance rate. The figures identify interviews as a significant strategic consideration in the available examination record.

Natera Inc., Massachusetts Institute of Technology, and Wisconsin Alumni Research Foundation are the listed companies. The listed firms are FOLEY & LARDNER LLP, HOWSON & HOWSON LLP, and WOLF GREENFIELD & SACKS, P.C. The case volume supports reviewing recurring substantive issues across matters. Counsel may prioritize interview preparation while planning for the recorded duration and the allowance outcome shown in this art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

46.5%
Allow Rate
-18.5% vs TC avg
820
Total Applications
+53.8%
Interview Lift
1378
Avg Prosecution Days
Based on 742 resolved cases, 2023–2026

Rejection Statute Breakdown

23.4%
§101 Eligibility
11.3%
§102 Novelty
22.3%
§103 Obviousness
34.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18010878 CLEAVAGE-AMPLIFICATION BIOSENSOR AND METHODS OF USE THEREOF Non-Final OA McMaster University
18168955 METHODS OF DETERMINING COVID-19 MORTALITY RISK Non-Final OA WASHINGTON UNIVERSITY
18426589 GENE ANALYSIS METHOD AND KIT FOR GENE ANALYSIS Non-Final OA HITACHI, LTD.
17794269 AN EPIGENETIC CLOCK FOR GALLIFORMES Final Rejection EVONIK OPERATIONS GMBH
18042167 BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS Final Rejection OTSUKA PHARMACEUTICAL CO., LTD.
18267038 DIAGNOSTICS AND THERAPEUTICS FOR EBV IN MS AND OTHER AUTOIMMUNE DISEASES Non-Final OA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
18691868 APPARATUSES, SYSTEMS, AND METHODS FOR DETECTING BIOMARKERS ASSOCIATED WITH RISK OF PRESSURE INJURIES Non-Final OA CASE WESTERN RESERVE UNIVERSITY
18681271 COMPOSITIONS AND METHODS FOR FAST MULTIPLEXED SCREENING AND MONITORING OF NPM1 MUTATIONS Non-Final OA The University of Hong Kong

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Stephen Thomas Kapushoc's allowance rate?

46.5% of resolved applications examined by Stephen Thomas Kapushoc were allowed (742 resolved cases), compared with 30.4% across Art Unit 1634 over the last five years.

Does an interview help with examiner Stephen Thomas Kapushoc?

This examiner's interview lift is +53.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Stephen Thomas Kapushoc take to allow a patent?

Applications allowed by Stephen Thomas Kapushoc took 1,378 days on average from filing to allowance.

Which art unit does examiner Stephen Thomas Kapushoc work in?

Stephen Thomas Kapushoc examines applications in Art Unit 1634 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month